Despite their popularity, GLP-1 agonists may contribute to the risk of kidney stone formation in some patients, particularly during the initial phases of treatment, but their long-term metabolic benefits may reduce stone risk over time
Third-Party Tested: Independently verified for purity and potency
Noom Launches Free Version of Its Powerful GLP-1 Companion Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider
Body weight should be assessed and, if possible, compared with that of previous visits (even those noted on a clinical record from another veterinarian)
